Pharmaceuticals

This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.

The startup company Genetesis introduced a new cardiac imaging modalityit calls magnetocardiography. The scanner creates images from the biomagnetic activity of the heart, using the polarization and depolarization of the heart during the cardiac cycle. This was at AHA.18, AHA 2018 - the American Heart Association annual meeting
Feature | AHA | Dave Fornell, Editor

Here are a few of the takeaways from the clinical studies presented and new technology shown on the exhibit floor at the ...

Home January 14, 2019
Home
News | Pharmaceuticals

January 10, 2019 — Aurobindo Pharma USA Inc. is conducting a voluntary recall of 80 lots of Amlodipine Valsartan Tablets ...

Home January 10, 2019
Home
The 2018 Most Popular Cardiology Topics - FDA approval of Andexxa, the first antidote indicated for patients treated with rivaroxaban (Xarelto) and apixaban (Eliquis), and new pacemaker technologies.
Feature | Dave Fornell, Editor

January 4, 2018 — Here is the top cardiology content on the Diagnostic and Interventional Cardiology (DAIC) website from ...

Home January 04, 2019
Home
News | Cardio-oncology

January 3, 2019 — Breast cancer patients who take a heart drug at the same time as trastuzumab have less heart damage ...

Home January 03, 2019
Home
News | Antiplatelet and Anticoagulation Therapies

January 2, 2019 — The U.S. Food and Drug Administration (FDA) has approved Portola Pharmaceuticals’ Prior Approval ...

Home January 02, 2019
Home
News | Antiplatelet and Anticoagulation Therapies

December 17, 2018 — Among otherwise healthy people, a daily dose of aspirin does not save lives and causes additional ...

Home December 17, 2018
Home
News | Pharmaceuticals

December 11, 2018 — Mylan Pharmaceuticals is expanding its consumer-level voluntary nationwide recall to include all ...

Home December 11, 2018
Home
News | Cardio-oncology

December 7, 2018 — New data from the Phase 3 CASSINI study showed a 60 percent reduction of venous thromboembolism (VTE ...

Home December 07, 2018
Home
News | Cardiac Diagnostics

November 30, 2018 — Healthcare technology company Livongo recently announced the launch of its Applied Health Signals ...

Home November 30, 2018
Home
News

November 16, 2018 — A research team led by scientists and doctors in Leicester and the Netherlands has shown that a ...

Home November 19, 2018
Home
News | Pharmaceuticals

November 15, 2018 — AstraZeneca announced positive full results from the DECLARE-TIMI 58 cardiovascular (CV) outcomes ...

Home November 15, 2018
Home
News | Pharmaceuticals

November 13, 2018 — A study in the current edition of the New England Journal of Medicine1 shows that a particular ...

Home November 13, 2018
Home
News | Heart Failure

November 6, 2018 – Initial results from the real-world EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) ...

Home November 07, 2018
Home
News | Antiplatelet and Anticoagulation Therapies

November 1, 2018 — A vaccine may one day be able to replace oral blood thinners to reduce the risk of secondary strokes ...

Home November 01, 2018
Home
Subscribe Now